Mission Statement, Vision, & Core Values of Phreesia, Inc. (PHR)

Phreesia, Inc.'s core principles aren't just abstract ideas; they are the engine behind a significant financial turnaround, moving the company from heavy losses toward profitability.

In fiscal 2025, the company delivered full-year revenue of $419.8 million, a jump of 18% year-over-year, and flipped its Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) from a significant loss to a $36.8 million positive, proving that mission-driven growth can defintely pay off.

You see the numbers, but do you know how their commitment to 'Making care easier every day' and their core value of 'Grit' actually translated into facilitating over 170 million patient visits, or 1 in 7 visits across the U.S.? Does their vision-that 'Every person is an active participant in their care'-align with the operational focus that drove their Adjusted EBITDA into the black, and what does that mean for your investment thesis?

Phreesia, Inc. (PHR) Overview

Phreesia, Inc. is a leading software-as-a-service (SaaS) company that has successfully digitized the patient intake and payment process, moving the needle on profitability in a tough market. For fiscal year 2025, the company delivered a total revenue of nearly $420 million, cementing its position as a core infrastructure provider in US healthcare.

Founded in 2005, Phreesia has spent two decades building a comprehensive platform that automates the administrative tasks that bog down healthcare providers. It's not just a check-in kiosk; it's a full-stack digital engagement solution. By 2024, the platform enabled approximately 170 million patient visits-that's roughly one in seven visits across the US, which is a massive footprint. Honestly, that scale is what matters most in this business.

The product portfolio is straightforward, but powerful:

• Phreesia Intake: Digital patient registration, insurance verification, and customizable questionnaires that cut down on clipboard time.
• Phreesia Payments: Secure patient payment processing, including online bill pay and flexible payment plans, which is a key revenue driver.
• Phreesia Connect: Targeted patient outreach, digital education, and adherence programs for life sciences companies, a high-growth market.

As of November 2025, the company's current sales momentum is strong, with the last twelve months (TTM) revenue reaching $449.67 million, showing continued top-line expansion.

Financial Performance: FY2025 and Near-Term Momentum

Let's look at the numbers because they tell the real story of the turnaround. Phreesia's fiscal year 2025 (FY2025, ended January 31, 2025) was a pivotal year, marked by a significant shift in profitability. Total revenue for FY2025 was $419.8 million, an 18% year-over-year increase.

The real highlight was the leap in Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), which is a clean measure of operating performance. The company swung from a negative Adjusted EBITDA of $35.4 million in FY2024 to a positive $36.8 million in FY2025. Here's the quick math: that's a $72.2 million improvement in operating leverage in a single year. Plus, they achieved positive free cash flow of $8.3 million for the full fiscal year 2025, a massive step for a growth-focused SaaS business.

Looking at the latest reported quarter, Q2 Fiscal Year 2026 (ended July 31, 2025), the momentum continued. Total quarterly revenue hit $117.3 million, up 15% year-over-year. Crucially, the company posted its first-ever GAAP net income-positive quarter, reporting $0.7 million in net income, compared to a net loss of $18.0 million in the prior-year period. This is defintely a key milestone.

• Full FY2025 Revenue: $419.8 million (up 18%).
• FY2025 Adjusted EBITDA: $36.8 million (major profitability swing).
• Q2 FY2026 Network Solutions Growth: Approximately 25% year-over-year.
• Average Healthcare Services Clients (AHSCs) reached 4,467 in Q2 FY2026.

A Leader in Patient Activation and Digital Health

Phreesia is not just surviving; it's setting the pace in the patient activation segment of Health Care Information Technology. The company's focus on integrated patient payments is a major growth engine, with patient payment volume processed through the platform hitting $1.25 billion in Q2 FY2026 alone. That's a huge transaction volume that speaks to their penetration in the revenue cycle management space.

The market recognizes this success; Phreesia was recently named to the 2025 Deloitte Technology Fast 500 list, which ranks the fastest-growing tech companies in North America. This kind of third-party validation confirms the value proposition is resonating with healthcare systems and providers who are desperate to streamline operations and improve cash flow. If you want to dig deeper into the institutional confidence behind this growth, you should check out Exploring Phreesia, Inc. (PHR) Investor Profile: Who's Buying and Why?

To be fair, the market is competitive, but Phreesia's scale and its strategic acquisition of AccessOne for $160 million, announced in September 2025, positions them to deepen their payment solutions by offering financing for healthcare receivables. This move expands their total addressable market and is a clear action to drive future revenue growth and maintain their leadership position.

Next Step: Finance should model the impact of the AccessOne acquisition on the FY2026 revenue guidance, focusing on the payment processing segment's projected growth rate by end of year.

Phreesia, Inc. (PHR) Mission Statement

You want to know what drives a high-growth health technology company like Phreesia, Inc. beyond the balance sheet, and honestly, it all comes back to a powerful, simple mission. Phreesia's mission statement is: Making care easier every day. This isn't just a marketing slogan; it's the strategic compass that guided them to a massive financial pivot in the last fiscal year, moving from a net loss of $136.9 million in FY 2024 to a much-improved net loss of $58.5 million in FY 2025. That kind of turnaround, coupled with a full-year revenue of $419.8 million in fiscal 2025, up 18% year-over-year, shows their mission is translating into real business momentum. This focus on 'easier care' is what makes the company a key player in the increasingly complex U.S. healthcare system.

The mission's significance lies in its clarity, which is crucial for a company operating at Phreesia's scale-they facilitate over 170 million patient visits annually, representing about one in seven visits across the entire U.S. When you have that much market penetration, every strategic decision, from product development to client support, has to be defintely aligned with simplifying the patient-provider interaction. Here's the quick math: easing administrative burden for a client base that large directly improves their bottom line and ours.

If you're looking for the deep dive on the investor side of this growth story, you should check out Exploring Phreesia, Inc. (PHR) Investor Profile: Who's Buying and Why?

Core Component 1: Making Care Easier (Operational Efficiency)

The first core component, Making Care Easier, is all about operational efficiency and streamlining the patient journey. For providers, this means cutting out the administrative friction that costs time and money. Phreesia's digital solutions for intake, scheduling, and payments are the engine here. This focus is why the company achieved a major financial milestone in fiscal 2025, swinging its Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) from a negative $35.4 million in the prior year to a positive $36.8 million. That's a $72.2 million swing, and it proves that making things 'easier' for clients creates real operating leverage for the business.

The system works by automating tasks that used to be a paper-based headache, which is a concrete value proposition. For instance, Phreesia's digital intake and payment processing solutions saved healthcare providers an estimated 1.1 billion pieces of paper in 2024 alone. That's not just a green initiative; it's a direct reduction in overhead and a speed-up of the check-in process. Less paper, more profit.

Core Component 2: Every Day (Scale and Sustainability)

The second component, Every Day, speaks to the sheer scale, reliability, and sustainability of their impact, which is essential for a publicly traded technology company. This isn't a one-time fix; it's a continuous, embedded service. The fact that they facilitate over 170 million patient visits a year means the 'easier' experience is delivered at massive, daily volume.

This commitment to consistent, high-impact delivery is what earned Phreesia a spot on TIME's 2025 List of the World's Top HealthTech Companies, receiving a 'very high' performance indicator in the Health Information & Management category. Also, being named to the 2025 Deloitte Technology Fast 500™ shows their growth isn't slowing down. The sustained growth and operational discipline are what give investors confidence in their long-term trajectory.

• Sustained scale: 170 million patient visits facilitated annually.
• Financial stability: Positive Adjusted EBITDA of $36.8 million in FY 2025.
• Industry recognition: Named to TIME's 2025 Top HealthTech Companies.

Core Component 3: Activating the Patient (Vision Alignment)

While the mission is about making care easier, the company's vision-Every person is an active participant in their care-reveals the third, deeper component: activating the patient. This is the 'why' behind the 'easier.' It's about using technology to empower the consumer, which is a significant trend for healthcare's future. You can't simplify care without engaging the patient.

Phreesia backs this up with tangible action. In fiscal 2025, they partnered with advocacy groups and non-profits to deliver $5.3 million in public health messaging to patients on a pro bono basis. This effort was focused on raising awareness and increasing screening rates for serious conditions like cancers and mental health issues. That's a direct, measurable investment in patient activation, using their platform's scale to drive better health outcomes, not just better check-in times. It's a smart move, too, because a more informed and engaged patient is a better client for the healthcare provider, which strengthens Phreesia's core business relationships.

Phreesia, Inc. (PHR) Vision Statement

You're looking at Phreesia, Inc.'s (PHR) guiding principles to understand the long-term investment thesis, and that's smart. A clear vision maps the path to future cash flow. The core takeaway is simple: Phreesia's vision is a focused, patient-centric mandate that directly translates into a massive, scalable business model, evidenced by their shift to profitability in key metrics.

The company facilitated more than 170 million patient visits in fiscal year 2025, which is roughly one in seven visits across the U.S. That's not a niche product; that's a fundamental piece of the American healthcare infrastructure. The vision is the engine for that scale.

Every Person is an Active Participant in Their Care

This single sentence is the entire Phreesia vision, and it's a powerful statement of purpose that cuts through the industry's complexity. It means moving beyond just being a check-in kiosk to becoming a true patient activation platform (PAP). For you, the investor, this means Phreesia is targeting higher-value services-like medication adherence and patient-reported outcomes-which command higher revenue per client.

This vision is a competitive moat. It forces the company to build products that patients actually want to use, not just tools providers are forced to adopt. Honestly, if the patient doesn't use it, the provider doesn't get the data, and the system fails. Phreesia's success is defintely tied to patient engagement.

Core Value: Care. A lot.

This value is the empathetic anchor to the vision, but it has a real financial impact. You can see it in the company's improved financial health, which allows them to invest more in client success. Here's the quick math: Phreesia's net loss improved dramatically in fiscal 2025 to $58.5 million, down from a loss of $136.9 million in the prior year. That's a massive step toward sustainable operations, which is the only way to genuinely show you 'Care. A lot.' long-term.

This focus on caring also drives the mission of 'Making care easier every day.' It means streamlining the administrative friction that frustrates both patients and providers. When you make a provider's life easier, they stick around. In fiscal 2025, the average number of healthcare services clients (AHSCs) grew to 4,203, an increase of 17% year-over-year. That client retention and growth is a direct result of solving their pain points, not just selling them software.

Core Values: Try it. and Grit.

In a technology business, 'Try it.' and 'Grit.' are code for aggressive innovation and operational discipline. The healthcare technology space is a regulatory minefield, so you need both to survive. 'Try it.' speaks to their willingness to launch new products, like their recent focus on improving medication adherence. 'Grit.' speaks to the sustained effort required to turn a high-growth, high-loss model into an efficient machine.

This is where the financial turnaround is clearest. Phreesia's total revenue for fiscal 2025 was a strong $419.8 million, an 18% jump year-over-year. But the real story is in the bottom line: Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), a key measure of operational cash flow, swung from a negative $35.4 million in the prior year to a positive $36.8 million in fiscal 2025. This demonstrates the grit to achieve operating leverage (getting more profit from each dollar of revenue) as the business scales.

• Revenue: $419.8 million (FY 2025).
• Adjusted EBITDA: $36.8 million (FY 2025 positive swing).
• AHSC Growth: 4,203 clients (up 17%).

To be fair, what this estimate hides is the continued need for investment in new products, but the shift to positive Adjusted EBITDA shows the business model is fundamentally sound as they pursue their vision. You can dive deeper into the numbers by checking out Breaking Down Phreesia, Inc. (PHR) Financial Health: Key Insights for Investors.

Core Value: Make Excellent Things Happen.

This value is about impact beyond the balance sheet. For a company focused on patient activation, 'excellent things' means improving public health outcomes and showing corporate social responsibility (CSR). This is a critical factor for attracting and retaining talent, plus it builds goodwill with their client base-hospitals and health systems.

In fiscal 2025, Phreesia partnered with advocacy groups to deliver $5.3 million in pro bono public health messaging to patients. This messaging helped raise awareness for cancer screenings and mental health conditions. That's a concrete example of their vision in action-using their platform to make every person an active participant in their care, not just their payment. It also shows a commitment to data privacy, which is non-negotiable in this sector. You can't make excellent things happen if you lose the trust of the patient data you handle.

Phreesia, Inc. (PHR) Core Values

When you evaluate a company like Phreesia, Inc., you need to look past the income statement and understand the principles that drive their product strategy and operational efficiency. For fiscal year 2025, Phreesia's revenue hit $419.8 million, an 18% jump year-over-year, but that growth isn't accidental. It's rooted in four simple, actionable core values: Care. A lot., Try it., Grit, and Make excellent things happen. These aren't just posters on a wall; they're the operating manual for a company that facilitated more than 170 million patient visits in fiscal 2025.

Honestly, the mission-Making care easier every day-is only possible if the team lives these values. You can dive deeper into the company's foundation here: Phreesia, Inc. (PHR): History, Ownership, Mission, How It Works & Makes Money.

Care. A lot.

This value is about an empathetic commitment to the patient experience and to the healthcare providers Phreesia serves. It means going beyond the transaction to focus on the human element of healthcare. If you're a financial professional, think of this as a long-term investment in customer lifetime value and brand equity, which defintely reduces churn.

The commitment to patient well-being is quantifiable. In fiscal 2025, Phreesia partnered with advocacy groups and non-profits to deliver $5.3 million in public health messaging to patients on a pro bono basis. That's real capital deployed to raise awareness for critical issues like cancer screenings and mental health conditions, directly supporting the vision that Every person is an active participant in their care. It's a clear signal that patient outcomes matter as much as the bottom line.

• Funded $5.3 million in pro bono health messaging.
• Joined Network Advertising Initiative for data privacy.
• Helped providers save an estimated 1.1 billion pieces of paper in 2024.

Try it.

In the fast-moving health tech space, Try it. is the value that drives innovation and agility. It's permission to experiment, fail fast, and iterate, which is crucial when you're dealing with complex systems like electronic health records (EHRs) and regulatory changes. For investors, this translates to a high Research and Development (R&D) velocity and a diverse product pipeline.

This value is demonstrated by the company's focus on expanding its platform to new areas. For example, the decision to acquire AccessOne, a market leader in patient financing solutions, was a move to Try it. in the healthcare receivables space. This expansion helps address the patient payment challenge, a major friction point in the care journey. The company's overall net loss for fiscal 2025 was $58.5 million, which, while a loss, reflects significant investment in R&D and strategic growth initiatives that embody this Try it. mindset.

Grit.

Grit is the financial analyst's favorite value: persistence, resilience, and the long-term focus required to overcome obstacles. In a competitive market, you need Grit to turn a net loss into a profit. This is where the rubber meets the road on operational efficiency and strategic execution.

Here's the quick math on execution: Phreesia reported a net loss of $58.5 million for the full fiscal year 2025, but they achieved a significant milestone in Q2 Fiscal 2026 (ended July 31, 2025) by reporting their first-ever net income positive quarter of $0.7 million. That shift from a negative Adjusted EBITDA of $35.4 million in fiscal 2024 to a positive $36.8 million in fiscal 2025 shows relentless focus and operational leverage. That's not luck; that's Grit paying off.

Make excellent things happen.

This is the capstone value, the demand for high standards and measurable impact across all stakeholders-patients, providers, and shareholders. It's the expectation that every project, from a new payment feature to a public health campaign, must deliver superior results.

A concrete example of Make excellent things happen is the company's work with the Colorectal Cancer Alliance, which won a Gold 2025 PM360 Pharma Choice Award. The campaign, which was delivered to patients over 45, drove more than 220,000 patient engagements to promote timely screening and diagnosis. The average revenue per healthcare services client (AHSC) in fiscal 2025 was nearly $100,000 ($99,884), which reflects the excellent value and outcomes they are delivering to their provider clients. You must deliver value to earn that kind of per-client spend.